BLCM might be putting in a bottom here at the VWAP from March low and the 50% retracement level of move off March low. Worth keeping on your radar.
Comment
VWAP from low did not hold. No plans for entry here.
Important to know that BLCM is a 24 mil mkt cap stock with an Immunotherapy/Oncology focus and they are working on solid tumors and Car-T therapy, which is pretty sexy stuff nowadays, keep an eye out for catalysts. I may initiate a small position before an upcoming data readout
Comment
Although it fell 20-30% below my initial proposed entry, BLCM actually looks quite attractive breaking above on high volume and now pulling back to the downtrend line
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.